Compound GLP-1 dosing claims: what TikTok gets wrong

What did @daybydaydesiree actually say?

Desiree says she's taking compounded tirzepatide and, instead of moving to her prescribed 8.5 mg dose, she used an AI chatbot (she calls it "Tract TPT") to calculate a unit equivalent for 7.5 mg. Her math: if 8.5 mg equals 50 units, she asked the AI what unit count would equal 7.5 mg, and it told her 44 units. She's now self-administering that adjusted amount to reduce side effects. She's upfront that she's not giving advice, but she is describing exactly how she did it in enough detail that followers could replicate it.

She also states, accurately, that compounded tirzepatide dosing doesn't mirror the Zepbound titration schedule (2.5 mg, 5 mg, 7.5 mg, etc.), which is a real and commonly misunderstood distinction between branded and compounded GLP-1/GIP medications.

Does the science back this up?

The core issue here is concentration variability, and it's not a minor footnote. Compounded tirzepatide preparations are not standardized. Two vials from two different 503A compounding pharmacies can have meaningfully different concentrations, which makes any unit-to-milligram conversion you calculate for one prescription irrelevant, or even dangerous, for another.

The FDA has documented concerns about compounded semaglutide and tirzepatide quality, including potency and sterility issues (FDA Drug Shortages Staff, 2023-2024 enforcement actions). A 2023 analysis in JAMA (Valisure, cited in commentary by Wouters et al., 2023) found significant variability in compounded GLP-1 products. The branded Zepbound titration protocol was designed around specific absorption kinetics and receptor binding studies. Compounded formulations have not been through that process. Using AI arithmetic to bridge the gap between a branded schedule and a compounded vial is not pharmacologically sound. The math might be internally consistent, but the inputs may be wrong from the start.

What did they get wrong (or right)?

She got one thing right: compounded GLP-1 dosing is genuinely different from branded titration schedules, and that confusion causes real problems for patients. Credit for naming it.

What she got wrong is more serious. First, she's treating unit-to-milligram conversions as a reliable calculation when compounded drug concentration is not guaranteed to be consistent batch to batch. Second, she's using an AI chatbot as a de facto prescriber to adjust a controlled titration. AI tools like the one she describes are not calibrated to individual pharmacokinetics, body weight, renal function, or the specific compounding pharmacy's formulation. Third, the framing of "I just wanna go up a little bit" obscures that she's unilaterally modifying a prescribed regimen. Her prescriber set 8.5 mg for a reason. That reason may or may not be good, but the answer is to call the prescriber, not to run the numbers through a chatbot. Self-adjusting GLP-1 doses can affect gastric emptying, blood glucose regulation, and tolerability in ways that aren't always immediately obvious.

What should you actually know?

If you're on compounded tirzepatide and want to titrate more slowly than your prescription suggests, that is a completely reasonable clinical conversation to have. Many prescribers will support a slower ramp. The problem isn't wanting to avoid side effects. The problem is the method she used to get there.

Compounded tirzepatide from a 503A pharmacy is not FDA-approved and does not carry the same quality guarantees as Zepbound. The concentration listed on the vial is what the compounding pharmacy claims, not what's been independently verified in your specific vial. Any unit conversion you calculate is only as accurate as that concentration figure.

If you want to take 7.5 mg equivalent of your compounded tirzepatide instead of 8.5 mg, the correct path is: contact your prescribing provider, explain you want a slower titration, and get a written adjusted protocol. Most telehealth platforms that prescribe compounded GLP-1s have messaging systems built for exactly this. Use them. Do not use an AI chatbot to perform dose arithmetic on a compounded injectable peptide.